Dr. Reddy's Laboratories Limited
RDY
$14.49
$0.140.98%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.82% | 9.84% | -0.71% | 16.99% | 1.01% |
| Total Depreciation and Amortization | 4.75% | 21.92% | 21.91% | 17.67% | 23.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 163.15% | -316.88% | -3.27% | 135.29% | -163.34% |
| Change in Net Operating Assets | 20.14% | 68.50% | 39.24% | 120.28% | 19.80% |
| Cash from Operations | 56.24% | 60.39% | 67.85% | 83.18% | 37.72% |
| Capital Expenditure | 11.66% | 33.50% | -30.88% | -40.17% | -84.86% |
| Sale of Property, Plant, and Equipment | -91.45% | -49.98% | -84.40% | -118.09% | -79.12% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -309.69% | -110.71% | 21.43% | 38.11% | 112.46% |
| Cash from Investing | -78.80% | 51.99% | 7.60% | -12.42% | 66.76% |
| Total Debt Issued | 391.02% | -84.67% | -99.34% | -1,404.80% | -64.30% |
| Total Debt Repaid | 5.88% | 45.06% | -8.67% | 4.89% | -143.90% |
| Issuance of Common Stock | 20.00% | -33.33% | 931.58% | -64.52% | 177.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 4.10% | -- | -- | -- |
| Other Financing Activities | 2.09% | -118.34% | -53.63% | -25.71% | -76.38% |
| Cash from Financing | 1,149.86% | -131.62% | -112.29% | -1,226.54% | -88.99% |
| Foreign Exchange rate Adjustments | 6,888.51% | 913.40% | 914.92% | 446.83% | -103.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 374.97% | -86.42% | -148.32% | 449.90% | 128.69% |